[go: up one dir, main page]

MX9707183A - Un proceso y formas de cristal de 2-metil-tieno-benzodiazepina. - Google Patents

Un proceso y formas de cristal de 2-metil-tieno-benzodiazepina.

Info

Publication number
MX9707183A
MX9707183A MX9707183A MX9707183A MX9707183A MX 9707183 A MX9707183 A MX 9707183A MX 9707183 A MX9707183 A MX 9707183A MX 9707183 A MX9707183 A MX 9707183A MX 9707183 A MX9707183 A MX 9707183A
Authority
MX
Mexico
Prior art keywords
benzodiazepine
thieno
methyl
crystal forms
olanzapine
Prior art date
Application number
MX9707183A
Other languages
English (en)
Other versions
MXPA97007183A (es
Inventor
Charles Arthur Bunnell
Barry Arnold Hendriksen
Samuel Dean Larsen
Original Assignee
Lilly Co Eli
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23621056&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX9707183(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli, Lilly Industries Ltd filed Critical Lilly Co Eli
Publication of MX9707183A publication Critical patent/MX9707183A/es
Publication of MXPA97007183A publication Critical patent/MXPA97007183A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicinal Preparation (AREA)

Abstract

La invencion proporciona la Forma II, una sustancia polimorfa estable y farmacéuticamente elegante de la olanzapina.
MXPA/A/1997/007183A 1995-03-24 1997-09-22 Un proceso y formas de cristal de 2-metil-tieno-benzodiazepina MXPA97007183A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US409,566 1982-08-19
US40956695A 1995-03-24 1995-03-24
US409566 1995-03-24
PCT/US1996/003917 WO1996030375A1 (en) 1995-03-24 1996-03-22 Process and crystal forms of 2-methyl-thieno-benzodiazepine

Publications (2)

Publication Number Publication Date
MX9707183A true MX9707183A (es) 1997-11-29
MXPA97007183A MXPA97007183A (es) 1998-07-03

Family

ID=

Also Published As

Publication number Publication date
EA199700262A1 (ru) 1998-02-26
AR002719A1 (es) 1998-04-29
ZA962342B (en) 1997-09-22
LT97148A (lt) 1998-01-26
PT733635E (pt) 2001-12-28
KR100399688B1 (ko) 2004-02-18
YU17796A (sh) 1999-03-04
EE9700232A (et) 1998-04-15
SV1996000031A (es) 1998-03-27
ATA902196A (de) 2000-01-15
SI0733635T1 (en) 2002-06-30
EP1095941B1 (en) 2003-10-08
PT1095941E (pt) 2004-02-27
CZ292688B6 (cs) 2003-11-12
GB2313835B (en) 1998-09-16
DE69614426D1 (de) 2001-09-20
TR199701017T1 (xx) 1998-01-21
SI1095941T1 (en) 2003-12-31
EP1445259B1 (en) 2006-06-28
IL117610A (en) 2001-08-26
DE69630324D1 (de) 2003-11-13
EP1445259A1 (en) 2004-08-11
DE69614426T2 (de) 2002-05-23
CN1179160A (zh) 1998-04-15
SE9703205D0 (sv) 1997-09-05
DK1095941T3 (da) 2004-02-16
PL322501A1 (en) 1998-02-02
DK108997A (da) 1997-11-12
BR9607790A (pt) 1998-07-07
ATE204280T1 (de) 2001-09-15
NZ306110A (en) 1998-09-24
DE69636313D1 (de) 2006-08-10
CH690579A5 (de) 2000-10-31
EE03489B1 (et) 2001-08-15
BG101900A (en) 1999-03-31
SI1445259T1 (sl) 2006-10-31
SK121897A3 (en) 1998-03-04
GB9719819D0 (en) 1997-11-19
SI9620040B (sl) 2002-02-28
EA000149B1 (ru) 1998-10-29
CA2214005A1 (en) 1996-10-03
HUP9802824A3 (en) 2000-01-28
ES2208220T3 (es) 2004-06-16
JPH11502535A (ja) 1999-03-02
PE44897A1 (es) 1997-10-22
HUP9802824A2 (hu) 1999-06-28
BG62619B1 (bg) 2000-03-31
LT4349B (lt) 1998-05-25
US5736541A (en) 1998-04-07
AP9701065A0 (en) 1997-10-31
AR010448A1 (es) 2000-06-28
TW513432B (en) 2002-12-11
LV12018A (lv) 1998-04-20
MY114701A (en) 2002-12-31
ES2266719T3 (es) 2007-03-01
ES2159346T3 (es) 2001-10-01
LV12018B (en) 1998-09-20
PA8353701A1 (es) 1998-09-18
PT1445259E (pt) 2006-10-31
DE19681286T1 (de) 1998-04-02
SK284143B6 (sk) 2004-10-05
DE69630324T2 (de) 2004-07-29
SI9620040A (sl) 1998-06-30
AU5427996A (en) 1996-10-16
CZ300097A3 (en) 1997-12-17
DE69636313T2 (de) 2007-05-31
CN1065536C (zh) 2001-05-09
CA2214005C (en) 2001-07-03
EP0733635A1 (en) 1996-09-25
EP0733635B1 (en) 2001-08-16
YU49478B (sh) 2006-05-25
CO4650278A1 (es) 1998-09-03
SE9703205L (sv) 1997-09-05
AP828A (en) 2000-04-28
AT406771B (de) 2000-08-25
ATE251627T1 (de) 2003-10-15
OA10510A (en) 2002-04-24
KR19980703188A (ko) 1998-10-15
NO974365L (no) 1997-09-22
RO118872B1 (ro) 2003-12-30
FI973750A0 (fi) 1997-09-22
IL117610A0 (en) 1996-07-23
AU706471B2 (en) 1999-06-17
NO314663B1 (no) 2003-04-28
PL183723B1 (pl) 2002-07-31
NO974365D0 (no) 1997-09-22
WO1996030375A1 (en) 1996-10-03
DK1445259T3 (da) 2006-10-16
HK1013988A1 (en) 1999-09-17
FI973750A7 (fi) 1997-09-22
ZA962344B (en) 1997-09-22
UA44765C2 (uk) 2002-03-15
DK0733635T3 (da) 2001-10-08
EG23659A (en) 2007-03-26
TW442488B (en) 2001-06-23
EP1095941A1 (en) 2001-05-02
LU90096B1 (fr) 1997-07-22
IS1896B (is) 2003-10-20
HU224989B1 (en) 2006-05-29
IS4564A (is) 1997-09-22
FI973750L (fi) 1997-09-22
GB2313835A (en) 1997-12-10
ATE331719T1 (de) 2006-07-15

Similar Documents

Publication Publication Date Title
GB2313835A (en) Process and crystal forms of 2-Methyl-Thieno-Benzodiazepine
FI973749A7 (fi) Suun kautta annosteltava 2-metyylitienobentsodiatsepiinivalmiste
ES2180899T3 (es) Dihidrato d de olanzapina.
DK0850426T3 (da) Transpondearrangement
DE69525980D1 (de) Elektronenquelle
DE59607667D1 (de) Transportable Gehhilfe
ID24108A (id) Solvat eritromisin a oksim
ES2145221T3 (es) Procedimiento para preparar nizatidina pura.
ECSP961697A (es) Procedimiento y formas cristalinas de 2- metil- tieno- benzodiacepina x-8917a
KR960033076U (ko) 발광이어폰
KR960033540U (ko) 음경 보형물
HN1996000014A (es) Procedimiento y formas cristalinas de 2-metil-tieno-benzodiacepina.
KR970046824U (ko) 웨이퍼 플랫존 정렬장치
KR970004261U (ko) 음경 보조구
KR960033308U (ko) 신발끈 고리쇠 자동체결기의 고리쇠 공급장치
NO992244D0 (no) AIDS-legemiddel
KR960030461U (ko) 음경용 링
KR970020851U (ko) 콘돔
KR960030462U (ko) 콘돔
KR970012147U (ko) 팔찌용 지압구
KR960028124U (ko) 야광 열쇠고리
KR960030185U (ko) 발광 장신구
KR970016241U (ko) 음경용 링
KR960033543U (ko) 음경용 링
JO1926B1 (en) The process of forming crystalline forms of 2- methyl tinzo benzodiazepine

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees